More recently, Jung et al. [45] reached a similar conclusion and suggested that TG2-induced resistance to bortezomib in mantle cell lymphoma is mediated via NF-κB activation and that TG2 activity was essential for promoting the chemoresistance. Here, TGM2 is linked to mantle cell lymphoma.